The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Humacyte Inc’s current trading price is -73.03% away from its 52-week high, while its distance from the 52-week low is 129.57%. The stock’s price range for this period has been between $1.15 and $9.79 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 2.56 million for the day, a number notably lower than the average daily volume of 4.81 million over the last three months.
Humacyte Inc ‘s stock market performance has been somewhat erratic.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Humacyte Inc (HUMA) has experienced a quarterly decline of -12.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 409.51M and boasts a workforce of 220 employees.
Analyzing Trading Volume and Moving Average Trends
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for HUMA stands at 2.28. Similarly, the long-term debt-to-equity ratio is also 2.15.
HUMA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -47.72%. However, over the last six months, the performance has been stronger by -41.20%. The price of HUMA increased 121.85% over the last 30 days. And in the last five days, it has surged by 1.15%.
